Literature DB >> 1364200

The Pf332 gene codes for a megadalton protein of Plasmodium falciparum asexual blood stages.

D Mattei1, A Scherf.   

Abstract

We characterized the Plasmodium falciparum antigen 332 (Ag332) which is specifically expressed during the asexual intraerythrocytic cycle of the parasite. The corresponding Pf332 gene has been located in the subtelomeric region of chromosome 11. Furthermore, it is present in all strains so far analyzed and shows marked restriction length fragment polymorphism. Partial sequence and restriction endonuclease digestion of cloned fragments revealed that the Pf332 gene is composed of highly degenerated repeats rich in glutamic acid. Mung been nuclease digestion and Northern blot analysis suggested that the Pf332 gene codes for a protein of about 700 kDa. These data were further confirmed by Western blot and immunoprecipitation of parasites extracts with an antiserum raised against a recombinant clone expressing part of the Ag332. Confocal immunofluorescence showed that Ag332 is translocated from the parasite to the surface of infected red blood cells within vesicle-like structures. In addition, Ag332 was detected on the surface of monkey erythrocytes infected with Plasmodium falciparum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1364200     DOI: 10.1590/s0074-02761992000700026

Source DB:  PubMed          Journal:  Mem Inst Oswaldo Cruz        ISSN: 0074-0276            Impact factor:   2.743


  8 in total

1.  Interaction of the exported malaria protein Pf332 with the red blood cell membrane skeleton.

Authors:  Karena L Waller; Lisa M Stubberfield; Valentina Dubljevic; Donna W Buckingham; Narla Mohandas; Ross L Coppel; Brian M Cooke
Journal:  Biochim Biophys Acta       Date:  2010-02-02

2.  Antibody responses to the repetitive Plasmodium falciparum antigen Pf332 in humans naturally primed to the parasite.

Authors:  N Ahlborg; D Haddad; A B Siddique; C Roussilhon; C Rogier; J F Trape; M Troye-Blomberg; K Berzins
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

3.  Antibody responses to a C-terminal fragment of the Plasmodium falciparum blood-stage antigen Pf332 in Senegalese individuals naturally primed to the parasite.

Authors:  E Israelsson; H Balogun; N-M Vasconcelos; J Beser; C Roussilhon; C Rogier; J F Trape; K Berzins
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

4.  Characterization of the Duffy-Binding-Like Domain of Plasmodium falciparum Blood-Stage Antigen 332.

Authors:  Sandra Nilsson; Kirsten Moll; Davide Angeletti; Letusa Albrecht; Inari Kursula; Ning Jiang; Xiaodong Sun; Klavs Berzins; Mats Wahlgren; Qijun Chen
Journal:  Malar Res Treat       Date:  2011-09-19

5.  Characterization of the small exported Plasmodium falciparum membrane protein SEMP1.

Authors:  Olivier Dietz; Sebastian Rusch; Françoise Brand; Esther Mundwiler-Pachlatko; Annette Gaida; Till Voss; Hans-Peter Beck
Journal:  PLoS One       Date:  2014-07-25       Impact factor: 3.240

6.  Plasmodium falciparum antigen 332 is a resident peripheral membrane protein of Maurer's clefts.

Authors:  Sandra Nilsson; Davide Angeletti; Mats Wahlgren; Qijun Chen; Kirsten Moll
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

7.  A novel DBL-domain of the P. falciparum 332 molecule possibly involved in erythrocyte adhesion.

Authors:  Kirsten Moll; Arnaud Chêne; Ulf Ribacke; Osamu Kaneko; Sandra Nilsson; Gerhard Winter; Malin Haeggström; Weiqing Pan; Klavs Berzins; Mats Wahlgren; Qijun Chen
Journal:  PLoS One       Date:  2007-05-30       Impact factor: 3.240

8.  Relationship between Antibody Levels, IgG Binding to Plasmodium falciparum-Infected Erythrocytes, and Disease Outcome in Hospitalized Urban Malaria Patients from Dakar, Sénégal.

Authors:  Babacar Mbengue; Mouhamadou Mansour Fall; Maguette Sylla Niang; Birahim Niang; Marie Louise Varela; Antoine Marie Diatta; Moustapha Mbow; Kantome Ndiaye; Rokhaya Ndiaye Diallo; Alioune Dieye; Ronald Perraut
Journal:  Biomed Res Int       Date:  2016-08-03       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.